Search Results - "Fox, Terry L"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials by Lebwohl, Mark, Dinehart, Scott, Whiting, David, Lee, Peter K, Tawfik, Naji, Jorizzo, Joseph, Lee, James H, Fox, Terry L

    “…The immune system plays a critical role in the development and pathogenesis of actinic keratosis (AK). Imiquimod has been shown to stimulate the cutaneous…”
    Get full text
    Journal Article
  3. 3

    Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial by Marks, Robin, Gebauer, Kurt, Shumack, Stephen, Amies, Mark, Bryden, James, Fox, Terry L., Owens, Mary L.

    “…Background: Superficial basal cell carcinoma (sBCC) is an increasingly common tumor in fair-skinned populations throughout the world. Imiquimod, an immune…”
    Get full text
    Journal Article
  4. 4

    Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts by BEUTNER, K. R, TYRING, S. K, TROFATTER, K. F, DOUGLAS, J. M, SPRUANCE, S, OWENS, M. L, FOX, T. L, HOUGHAM, A. J, SCHMITT, K. A

    Published in Antimicrobial Agents and Chemotherapy (01-04-1998)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5

    Topical Imiquimod 5% Cream as an Effective Treatment for External Genital and Perianal Warts in Different Patient Populations by SAUDER, DANIEL N., SKINNER, ROBERT B., FOX, TERRY L., OWENS, MARY L.

    Published in Sexually transmitted diseases (01-02-2003)
    “…Background: Genital infection with human papillomavirus, the cause of genital warts, is one of the most common sexually transmitted diseases. Goal: The aim of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream by Beutner, Karl R., Geisse, John K., Helman, Donita, Fox, Terry L., Ginkel d, Angela, Owens, Mary L.

    “…Background: Basal cell carcinoma (BCC) responds to interferon therapy. Imiquimod is a cytokine and interferon inducer. Objective: This randomized, double-blind…”
    Get full text
    Journal Article
  8. 8

    Treatment of genital warts with an immune-response modifier (imiquimod) by Beutner, Karl R., Spruance, Spotswood L., Hougham, Andrina J., Fox, Terry L., Owens, Mary L., Douglas, John M.

    “…Background: Genital warts are a common sexually transmitted disease caused by human papillomavirus. Imiquimod is a novel immune-response modifier capable of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Developmental field defects: Coming together of associations and sequences during blastogenesis by Hersh, Joseph H., Angle, Brad, Fox, Terry L., Barth, Rolf F., Bendon, Robert W., Gowans, Gordon

    Published in American journal of medical genetics (15-07-2002)
    “…We report on two patients with an unusual combination of multiple congenital anomalies including holoprosencephaly, encephalocele, and additional defects…”
    Get full text
    Journal Article
  11. 11
  12. 12

    An examination of the decision styles of project managers: Evidence of significant diversity by Fox, Terry L., Spence, J.Wayne

    Published in Information & management (01-12-1999)
    “…It has been suggested that the manner in which a project manager makes decisions can significantly influence his or her effectiveness and ultimately the design…”
    Get full text
    Journal Article
  13. 13

    An examination of the effect of decision style on the use of a computerized project management tool by Fox, Terry L

    Published 01-01-1997
    “…Managing a software development project presents many difficulties. Most software development projects are considered less than successful, and many are simply…”
    Get full text
    Dissertation
  14. 14

    Percutaneous penetration of Aldara™ cream, 5% during the topical treatment of genital and perianal warts by Owens, Mary L., Bridson, William E., Smith, Sheri L., Myers, Jane A., Fox, Terry L., Wells, Teresa M.

    Published in Primary care update for Ob/Gyns (01-07-1998)
    “…Objective: The objective of this single-center, open-label trial was to evaluate the percutaneous penetration of Aldara™ (imiquimod) cream, 5% when applied…”
    Get full text
    Journal Article